CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CGON is expected to report earnings to rise 4.35% to -47 cents per share on March 27
Q4'25
Est.
$-0.48
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.12
Q1'24
Missed
by $0.01
The last earnings report on March 28 showed earnings per share of -46 cents, missing the estimate of -44 cents. With 561.99K shares outstanding, the current market capitalization sits at 3.21B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGON showed earnings on March 28, 2025. You can read more about the earnings report here.